Treatment Modalities in Lung Cancer
|
|
- Nicholas Warren
- 5 years ago
- Views:
Transcription
1 Workshop on Combined Radiotherapy and Chemotherapy Modalities in Lung Cancer, organised by the International Association for the Study of Lung Cancer (IASLC), Le Havre, June 9-13, 1987 Treatment Modalities in Lung Cancer Volume Editors R. Arriagada, Villejuif T. Le Chevalier, Villejuif Associate Editors J.R. Bertino, New York, N.Y.; N.M. Bleehen, Cambridge; J.H. Goldie, Vancouver; H.H. Hansen, Copenhagen; D.C. Ihde, Bethesda, Md. 40 figures and 50 tables, 1988 Basel Miinchen Paris London New York NewDelhi Singapore Tokyo Sydney
2 List of Participants XI Inaugural Conference Tubiana, M. (Villejuif): The Combination of Radiotherapy and Chemotherapy.. 1 Mathematical Models Goldie, J.H.; Coldman, A.J.; Ng, V. (Vancouver, B.C.); Hopkins, H.A.; Looney, W.B. (Charlottesville, Va.): A Mathematical and Computer-Based Model of Alternating Chemotherapy and Radiation Therapy in Experimental Neoplasms 11 Souhami, R.L.; Gregory, W.M.; Birkhead, B.G. (London): Mathematical Models in High-Dose Chemotherapy 21 Biological Bases and Mechanisms of Cell Resistance to Therapy Bertino, J.R. (New York, N. Y.): Review of Mechanisms of Cell Resistance to Therapy in Lung Cancer 29 Looney, W.B.; Hopkins, H.A. (Charlottesville, Va.): The Relationship of Experimental, Theoretical and Clinical Studies of Alternating Chemotherapy and Radiotherapy in the Management of Lung Cancer 35 Milas, L. (Houston, Tex.): Effects of Radiotherapy and Chemotherapy on Tumor Bed Stroma.." 48
3 VIII Treatment Response Evaluation and Statistical Analysis Sorensen, J.B.; Hansen, H.H. (Copenhagen): Review of Methodological Problems in the Interpretation of Phase II Trials in Nonsmall-Cell Lung Cancer 57 Ihde, D.C. (Bethesda, Md.): How Should We Report Results of Clinical Trials of Combined Chemotherapy and Chest Irradiation in Limited Stage Small Cell Lung Cancer? 65 Choi, N.C.; Carey, R.W. (Boston, Mass.): Reassessment of Loco-Regional Failure Rate in Relation with Radiation Dose in Combined Modality Approach of Multidrug Chemotherapy and Radiotherapy for Limited Stage Small-Cell Lung Carcinoma 70 Souhami, R.L.; Earl, H.M.; Ash, CM.; Spiro, S.G.; Geddes, D.; Harper, P.G.; Tobias, J.S. (London): Prognostic Factors in Patients with Small-Cell Lung Cancer: Preliminary Results from a Large Randomised Study 77 B6nichou, J.; Chastang, C. (Paris): Use of the Triangular Test in the Analysis of Randomized Clinical Trials when the Response Criterion is Censored: Application to Two Trials in Lung Cancer 83 Concurrent Combinations Ihde, D.C; Seifter, E.J.; Johnson, B.E.; Glatstein, E. (Bethesda, Md.): Review of Concurrent Chemotherapy/Radiotherapy Combinations in Small Cell Lung Cancer 92 Payne, D.G.; Feld, R. (Toronto, Ont.): Concurrent Radiotherapy and Chemotherapy in Lung Cancer at the Princess Margaret Hospital 96 Lange, O.F. (Bonn): Concurrent Chemo-Radiotherapy in Small Cell Lung Cancer. 102 Turrisi, A.T.; Glover, D.J.; Mason, B.A. (Philadelphia, Pa.): Concurrent Twice- Daily Radiotherapy Plus Platinum-Etoposide Chemotherapy for the Treatment of Limited Small Cell Lung Cancer: A Preliminary Report 109 Sequential Combinations Bleehen, N.M. (Cambridge): Review of Sequential Radio-Chemotherapy Schedules in the Treatment of Lung Cancer 115 Trovo, M.G.; Veronesi, A.; Bortolus, R.; Roncadin, M.; De Paoli, A.; Franchin, G.; Grigoletto, E.; Minatel, E. (Aviano): Is Chemotherapy Necessary in the Management of Unresectable Nonmetastatic Nonsmall-Cell Lung Cancer? Van Houtte, P.; Klastersky, J. (Brussels); Renaud, A.; Michel, J. (La Louvriere); Vandermoten, G.; Nguyen, H.; Sculier, J.P.; Devriendt, J.; Mommen, P. (Brussels): Induction Chemotherapy with Cisplatin, Etoposide and Vindesine before Radiiiiation Therapy for Nonsmall-Cell Lung Cancer. A Randomized Study. 131 Thomas, F.; Le Chevalier, T.; Arriagada, R.; Ruffie\ P.; Baldeyrou, P. (Villejuif): Should Chemotherapy Response Be Evaluated Separately in Sequential Chemotherapy-Radiotherapy Schedules in Locally Advanced Nonsmall-Cell Lung Carcinoma? 138 Aisner, J. (Baltimore, Md.): Combined Modalities in the Treatment of Small Cell Carcinoma of the Lung. A Review of Current Standings 142
4 IX Unconventional Combinations Arriagada, R. (Villejuif): Review of Unconventional Combinations of Radiotherapy and Chemotherapy in Lung Cancer 150 Souhami, R.L.; Ash, CM.; Earl, H.M.; Harper, P.G.; Geddes, D.; Tobias, J.S.; Spiro, S.G. (London): Intensive Chemotherapy and Thoracic Irradiation as Induction Treatment in Limited-Stage Small-Cell Lung Cancer 155 Dionet, C; Verrelle, P.; Roux, D.; Fraysse, P.; Achard, J.-L.; Beaupain, R.; Rozan, R. (Clermont-Ferrand): Role of Small Doses of Radiotherapy Combined with Chemotherapy in Non-Small Cell Lung Cancer 163 Hurman, D.C; Urtasun, R.C; Belch, A.R.; Kinney, B.; Amy, R.; Hanson, J. (Alberta, Ed.); Feldstein, M. (Boston, Mass.): Sequential Wide Field Irradiation and Systemic Chemotherapy as Part of the Induction Treatment of Small Cell Lung Cancer 168 Looney, W.B.; Hopkins, H.A. (Charlottesville, Va.): The Integration of Multifractionated Radiotherapy into Combined Chemotherapeutic-Radiotherapeutic s Approaches to Lung Cancer Treatment 176 Scher, H.; Gralla, R.; Linares, L.; Kris, M.; Heelan, R.; Shank, B. (New York, N.Y.): Preliminary Results of Combination Chemotherapy and Sequential Accelerated Fractionation Radiation Therapy in Limited-Stage Small Cell Carcinoma of the Lung. Evaluation of Measures for Reduction of Toxicity and Effect on Complete Response Rate 184 Le Chevalier, T.; Arriagada, R.; Thomas, F.; Baldeyrou, P.; Ruffle, P. (Villejuif); Cremoux, H. de; Martin, M. (Creteil); Cerrina, M.L. (Clamart); De The\ H.; Tarayre, M.; Sancho-Garnier, H.; GROP (Villejuif): Experience of the Institut Gustave-Roussy in Alternating Radiotherapy and Chemotherapy Schedules as Induction Treatment in Limited Small-Cell Lung Cancer 190 Arriagada, R.; De Th6, H.; Thomas, F. (Villejuif); Cremoux, H. de (Cr&eil); Dewar, J.; Sancho-Garnier, H.; Le Chevalier, T.; GROP (Villejuif): Prognostic Value of Initial Chemotherapy Doses in Limited Small Cell Lung Cancer 194 Treatment Toxicity and Long-Term Sequelae Le Chevalier, T. (Villejuif): Review of Toxicity and Long-Term Sequelae in Lung Cancer 199 Feld, R.; Payne, D.; Hodson, I.; Coy, P. for the NCI Clinical Trials Group (Toronto, Ont.): Complications of Treatment of Small Cell Carcinoma of the Lung Johnson, B.E.; Glatstein, E.; Ihde, D.C. (Bethesda, Md.): The National Cancer Institute Experience with Early and Late Effects of Combined Modality Therapy in Small Cell Lung Cancer 210 Choi, N.C; Kanarek, D.J.; Kazemi, H. (Boston, Mass.): Prospective Study of Pulmonary Tolerance to Radiotherapy or Radiotherapy plus Multidrug Chemotherapy for Loco-Regional Lung Carcinoma 213 Souhami, R.L.; Morittu, L.; Ash, CM.; Earl, H.; Geddes, D.; Harper, P.G.; Tobias, J.S.; Spiro, S.G. (London): Identification of Patients at High Risk of Chemotherapy-Induced Toxicity in Small-Cell Lung Cancer 220
5 X Kaasa, S.; Olsnes, B.T.; Thorud, E.; Hast, H. (Oslo): Reduced Short-Term Neuropsychological Performance in Patients with Nonsmall-Cell Lung Cancer Treated with Cisplatin and Etoposide 226 Consensus Report Arriagada, R.; Bertino, J.R.; Bleehen, N.M.; Brodin, O.; Feld, R.; Goldie, J.H.; Hansen, H.H.; Ihde, D.C; Le Chevalier, T.; Souhami, R.L. and the Workshop Participants: Consensus Report on Combined Radiotherapy and Chemotherapy Modalities in Lung Cancer 232 Subject Index 242
Lung cancer is common and difficult to treat. By
Chemotherapy plus Radiotherapy Compared with Radiotherapy Alone in the Treatment of Locally Advanced, Unresectable, Non-Small-Cell Lung Cancer A Meta-Analysis Robert S. Pritchard, MD, MS, and Stephen P.
More informationCALGB Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer
CALGB 30610 Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer Jeffrey A. Bogart Department of Radiation Oncology Upstate Medical University Syracuse, NY Small Cell Lung Cancer Estimated 33,000
More informationThe New England Journal of Medicine PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG CANCER IN COMPLETE REMISSION
PROPHYLACTIC CRANIAL IRRADIATION FOR PATIENTS WITH SMALL-CELL LUNG CANCER IN COMPLETE REMISSION ANNE AUPÉRIN, M.D., RODRIGO ARRIAGADA, M.D., JEAN-PIERRE PIGNON, M.D., PH.D., CÉCILE LE PÉCHOUX, M.D., ANNA
More informationProgress in Experimental Tumor Research
COX-2 Progress in Experimental Tumor Research Vol. 37 Series Editor Joseph R. Bertino, New Brunswick, N.J. Basel Freiburg Paris London New York Bangalore Bangkok Singapore Tokyo Sydney COX-2 A New Target
More informationChemotherapy in Lung Cancer
Special Issue Chemotherapy in Lung Cancer Keunchil Park, M.D. Division of Hematology / Oncology, Department of Medicine Sungkyunkwan University School of Medicine, Samsung Medical Center E-mail : kpark@smc.samsung.co.kr
More information1 Oregon Health & Science University, Portland, OR 2 Stritch School of Medicine, Loyola University Chicago, Chicago, IL
Current treatment practices for limited-stage small cell lung cancer: A survey of US radiation oncologists on the timing of thoracic radiotherapy with chemotherapy Matthew J. Farrell 1, Jehan Yahya 1,
More informationPulmonary function tests 3. Is patient potentially operable? Yes. Inoperable. Yes. Zubrod performance status
te: Consider Clinical Trials as treatment options for eligible patients. INITIAL EVALUATION Pathology consistent with SCLC History and physical Chest x-ray Laboratory studies to include hematological and
More informationOriginal Study. 40 Clinical Lung Cancer January 2013
Original Study Prophylactic Cranial Irradiation for Patients With Limited-Stage Small-Cell Lung Cancer With Response to Chemoradiation Patricia Tai, 1 Avi Assouline, 2 Kurian Joseph, 3 Larry Stitt, 4 Edward
More informationSMALL-CELL CARCINOMA of the lung contributes
Does Thoracic Irradiation Improve Survival and Local Control in Limited-Stage Small-Cell Carcinoma of the Lung? A Meta-Analysis By P. Warde and D. Payne Purpose: Our main purpose was to determine whether
More informationPulmonary Complications of Cancer Treatment
Pulmonary Complications of Cancer Beth Zigmund, MD Objectives (Preliminary Version) Beth Zigmund, MD Develop awareness of the myriad pulmonary complications of cancer treatment and of challenge in making
More informationTratamiento Multidisciplinar de Estadios Localmente Avanzados en Cáncer de Pulmón
Tratamiento Multidisciplinar de Estadios Localmente Avanzados en Cáncer de Pulmón Santiago Ponce Aix Servicio Oncología Médica Hospital Universitario 12 de Octubre Madrid Stage III: heterogenous disease
More informationThe Role of Thoracic Radiotherapy as an Adjunct to Standard Chemotherapy in Limited-Stage Small Cell Lung Cancer
Evidence-based Series # 7-13-3 EDUCATION AND INFORMATION 2013 The Role of Thoracic Radiotherapy as an Adjunct to Standard Chemotherapy in Limited-Stage Small Cell Lung Cancer Members of the Lung Cancer
More informationThe Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer
Curr. Treat. Options in Oncol. (2015) 16: 56 DOI 10.1007/s11864-015-0372-2 Lung Cancer (HA Wakelee, Section Editor) The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer Kaname Nosaki, M.D.
More informationIntroduction: Methods: Results: Conclusions: PATIENTS AND METHODS Key Words: 1770
Original Article Utilization of Hyperfractionated Radiation in Small-Cell Lung Cancer and Its Impact on Survival David Schreiber, MD,* Andrew T. Wong, MD,* David Schwartz, MD,* and Justin Rineer, MD Introduction:
More informationBody Image, Self-Esteem, and Sexuality in Cancer Patients
Body Image, Self-Esteem, and Sexuality in Cancer Patients Frontiers of Radiation Therapy and Oncology Vo1.14 Series Editor Jerome M. Vaeth, San Francisco, Calif. Associate Editors Jerold P. Green, Alan
More informationM. A. SOCINSKI, L.B. MARKS, J. GARST, G.S. SIBLEY, W. BLACKSTOCK, A. TURRISI, J. HERNDON, S. ZHOU, M. ANSCHER, J. CRAWFORD, T. SHAFMAN, J.
Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: A Preliminary Report of a Phase I Dose Escalation Trial from the Carolina Conformal
More informationThymic Tumors KARGER. 7th Cancer Research Workshop, Grenoble, October 15-17, Editors R. Sarrazin, C. Vrousos, F.
Thymic Tumors 7th Cancer Research Workshop, Grenoble, October 15-17, 1987 Thymic Tumors Editors R. Sarrazin, C. Vrousos, F. Vincent, Grenoble 52 figures and 39 tables, 1989 KARGER Basel München Paris
More informationProphylactic cranial irradiation or no prophylactic cranial irradiation in metastatic small cell lung cancer: is it a relevant question once again?
Editorial Prophylactic cranial irradiation or no prophylactic cranial irradiation in metastatic small cell lung cancer: is it a relevant question once again? Cecile Le Pechoux 1, Angela Botticella 1, Antonin
More informationClinical Management Guideline for Small Cell Lung Cancer
Diagnosis and Staging: Key Points 1. Ensure a CT scan that is
More informationSmall Cell Lung Cancer (SCLC)
te: Consider Clinical Trials as treatment options for eligible patients. INITIAL EVALUATION Small Cell Lung Cancer (SCLC) Page 1 of 8 STAGE FURTHER ASSESSMENT Pathology consistent with SCLC History and
More informationCombined chemoradiotherapy in the treatment of locally advanced non-small cell lung cancer
Journal of BUON 7: 47-51, 2002 2002 Zerbinis Medical Publications. Printed in Greece ORIGINAL ARTICLE Combined chemoradiotherapy in the treatment of locally advanced non-small cell lung cancer S. Isaković-Vidović,
More informationEffect of early chemoradiotherapy in patients with limited stage small cell lung cancer
Original Article Radiat Oncol J 2013;31(4):185-190 http://dx.doi.org/10.3857/roj.2013.31.4.185 pissn 2234-1900 eissn 2234-3156 Effect of early chemoradiotherapy in patients with limited stage small cell
More informationof the United Kingdom Coordinating Committee on Cancer Research
'." Br. J. Cancer Cancer (1990), (1990), 61, 597-604 Macmillan Press Ltd., 1990 61, 597-604 Macmillan Press Ltd., 1990~~~~~ An overview of prognostic factors in small cell lung cancer A report from the
More informationRESEARCH ARTICLE. Evrim Bayman 1 *, Durmus Etiz 1, Melek Akcay 1, Guntulu Ak 2. Abstract. Introduction
DOI:http://dx.doi.org/10.7314/APJCP.2014.15.15.6263 RESEARCH ARTICLE Timing of Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: Results of Early Versus Late Irradiation from a Single Institution
More informationKAR.GER. Antibiotics and Chemotherapy. Vol. 45. Series Editor H. SchOnfeld, Grenzach
Bacterial Meningitis Antibiotics and Chemotherapy Vol. 45 Series Editor H. SchOnfeld, Grenzach KAR.GER. Basel Miinchen Paris London New York. New Delhi Bangkok Singapore Tokyo Sydney Bacterial Meningitis
More informationEmesis in Anti-cancer Therapy Mechanisms and treatment
Emesis in Anti-cancer Therapy Mechanisms and treatment Edited by P.L.R. Andrews Reader in Physiology St George's Hospital Medical School London UK and G.J. Sanger Director of Gastrointestinal Research
More informationAccepted Manuscript. Adjuvant Chemotherapy in Stage I Lung Cancer: Is More Better? Chuong D. Hoang, MD
Accepted Manuscript Adjuvant Chemotherapy in Stage I Lung Cancer: Is More Better? Chuong D. Hoang, MD PII: S0022-5223(18)31821-X DOI: 10.1016/j.jtcvs.2018.06.069 Reference: YMTC 13198 To appear in: The
More informationBefore any medical interventions are undertaken in patients
ORIGINAL ARTICLE Risk Factors for Treatment-Related Death Associated with Chemotherapy and Thoracic Radiotherapy for Lung Cancer Yuko Minami-Shimmyo, MD,* Yuichiro Ohe, MD, PhD,* Seiichiro Yamamoto, PhD,
More informationCombined modality treatment for N2 disease
Combined modality treatment for N2 disease Dr Clara Chan Consultant in Clinical Oncology 3 rd March 2017 Overview Background The evidence base Systemic treatment Radiotherapy Future directions/clinical
More informationFREQUENCY OF THORACIC RADIOTHERAPY WITH CHEMOTHERAPY IN LIMITED SMALL-CELL LUNG CANCER
TWICE-DAILY COMPARED WITH ONCE-DAILY THORACIC RADIOTHERAPY IN LIMITED SMALL-CELL LUNG CANCER TREATED CONCURRENTLY WITH CISPLATIN AND ETOPOSIDE ANDREW T. TURRISI, III, M.D., KYUNGMANN KIM, PH.D., RONALD
More informationOVERALL SURVIVAL IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER
OVERALL SURVIVAL IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER Author Chayawut Punsriwong Chayakamon Niyasom Pariphat Chompoonutprapa Sarut Pravitkulawath 5 th year medical student Naresuan University
More informationTHORACIC MALIGNANCIES
THORACIC MALIGNANCIES Summary for Malignant Malignancies. Lung Ca 1 Lung Cancer Non-Small Cell Lung Cancer Diagnostic Evaluation for Non-Small Lung Cancer 1. History and Physical examination. 2. CBCDE,
More informationEffect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma
ORIGINAL ARTICLE Effect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma Nader Abedallaa, MD,* Lise Tremblay, MD, Charlotte Baey,* Dominique Fabre, MD, David
More informationSUMMARY OF CHANGES Amendment 5, Version Date: March 24, 2010 Broadcast: 4/6/10
Amendment 5, Version Date: March 24, 2010 Broadcast: 4/6/10 RTOG 0239, "A Phase II Study Of Accelerated High Dose Thoracic Irradiation With Concurrent Chemotherapy For Patients With Limited Small Cell
More informationChemotherapy in lung cancer
Postgraduate Medical Journal (1989) 65, 291-298 Difficult Decisions Chemotherapy in lung cancer C.G.A. Price and M.L. Slevin I.C.R.F. Department ofmedical Oncology, St Bartholomew's and Homerton Hospitals,
More informationPhase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer
British Journal of Cancer (1999) 79(9/10), 1462 1467 1999 Cancer Research Campaign Article no. bjoc.1998.0233 Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced
More informationWhen approaching a patient with inoperable non-small
ORIGINAL ARTICLE Gemcitabine, Cisplatin, and Hyperfractionated Accelerated Radiotherapy for Locally Advanced Non-small Cell Lung Cancer Matjaz Zwitter, PhD, MD, Viljem Kovac, MSc, MD, Uros Smrdel, MD,
More informationPast, present and future of Radiotherapy of Lung Cancer
Past, present and future of Radiotherapy of Lung Cancer Joaquin G Mira MD, FACR START center Clinical professor, Univers. Texas Health Science Center, San Antonio, Texas Small cell lung cancer past, present
More informationMOLECULAR AND CLINICAL ONCOLOGY 2:
MOLECULAR AND CLINICAL ONCOLOGY 2: 805-810 A meta analysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin/carboplatin chemotherapy
More informationPlace de la radiothérapie dans les CBPC métastatiques
Place de la radiothérapie dans les CBPC métastatiques Cecile Le Péchoux, 12 ème Biennale Monégasque de Cancérologie, 2016 IOT Institut d Oncologie Thoracique CBPC metastatique Rapid doubling time, early
More informationCécile Le Péchoux Department of Radiation Oncology, Institut Gustave Roussy, Villejuif France Amsterdam 2010
Prophylactic Cranial Irradiation in Lung Cancer Cécile Le Péchoux Department of Radiation Oncology, Institut Gustave Roussy, Villejuif France Amsterdam 2010 Prophylactic cranial irradiation PCI was introduced
More informationSmall-cell lung cancer (SCLC) is an aggressive neuroendocrine
ORIGINAL ARTICLE Tolerability of Accelerated Chest Irradiation and Impact on Survival of Prophylactic Cranial Irradiation in Patients with Limited-stage Small Cell Lung Cancer: Review of a Single Institution
More informationManagement of advanced non small cell lung cancer
Management of advanced non small cell lung cancer Jean-Paul Sculier Intensive Care & Thoracic Oncology Institut Jules Bordet Université Libre de Bruxelles (ULB) www.pneumocancero.com Declaration No conflict
More informationProphylactic cranial irradiation in 399 patients with limited-stage small cell lung cancer
2654 Prophylactic cranial irradiation in 399 patients with limited-stage small cell lung cancer GUOQIN QIU, XIANGHUI DU, XIA ZHOU, WUAN BAO, LEI CHEN, JIANXIANG CHEN, YONGLING JI and SHENGYE WANG Department
More information5/20/ ) Haffty GB: Concurrent chemoradiation in the treatment of head and neck cancer. Hematol. Oncol. Clin: North Am.
Prague, 24-25 25 April 29 ALTERNATING CHEMORADIATION: FOR WHOM? M. Merlano MD Holy Cross Gen. Hospital Cuneo - Italy ALTERNATING CHEMORADIATION: FOR WHOM? Definition of alternating chemoradiation Targets
More informationChemotherapy Treatment Algorithms for Urology Cancer
Chemotherapy Treatment Algorithms for Urology Cancer Chemoradiation for bladder cancer; Chemotherapy algorithm for non TCC bladder cancer Squamous cell carcinoma; Chemotherapy Algorithm for Non Transitional
More informationREVIEW ARTICLE. Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer
REVIEW ARTICLE Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer Kate Haslett 1, Christoph Pöttgen 2, Martin Stuschke 2, Corinne Faivre-Finn 1,3 1 Radiotherapy Related Research,
More informationDr. Sause: Clinical, Research, and Administration. Vilija N. Avizonis, MD Radiation Oncologist; Intermountain Medical Center; Murray, Utah
Dr. Sause: Clinical, Research, and Administration Vilija N. Avizonis, MD Radiation Oncologist; Intermountain Medical Center; Murray, Utah Objectives: Identify Dr. Sause's educational achievements Discuss
More informationSingle Technology Appraisal (STA)
Single Technology Appraisal (STA) Durvalumab for maintenance treatment of locally advanced unresectable non-small cell lung cancer that has not progressed after platinum-based chemoradiation therapy Response
More informationStage III Non-Small Cell Lung Cancer, Is There Any Progress? HARMESH R NAIK, MD. KARMANOS CANCER INSTITUTE 2/24/99
Stage III Non-Small Cell Lung Cancer, Is There Any Progress? HARMESH R NAIK, MD. KARMANOS CANCER INSTITUTE 2/24/99 Introduction 1/3 of the total lung cancer cases few patients are cured with single modality
More informationSMALL CELL LUNG CANCER Updated Feb 2017 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary)
SMALL CELL LUNG CANCER Updated Feb 2017 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary) Reviewed by Dr. Desiree Hao (Staff Medical Oncologist, University of Calgary) and Dr.
More informationBasel München Paris London New York NewDelhi Singapore - Tokyo Sydney
Endocrine Management of Cancer 2 Contemporary Therapy Basil A. Stoll, London (Editor) Endocrine Management of Cancer 2 Contemporary Therapy 3 figures and 20 tables, 1988 KARGER Basel München Paris London
More informationNSCLC: Staging & Prognosis. Neoadjuvant chemotherapy. Controversies in the management of early NSCLC: neoadjuvant vs adjuvant chemotherapy
Controversies in the management of early NSCLC: neoadjuvant vs adjuvant Sarita Dubey sst Professor, Medical ncology, UCSF NSCLC: Staging & Prognosis Pathologic Survival elapse (%) Stage 5 yr (%) Local
More informationSelf-Assessment Module 2016 Annual Refresher Course
LS16031305 The Management of s With r. Lin Learning Objectives: 1. To understand the changing demographics of oropharynx cancer, and the impact of human papillomavirus on overall survival and the patterns
More informationCase presentation. Paul De Leyn, MD, PhD Thoracic Surgery University Hospitals Leuven Belgium
Case presentation Paul De Leyn, MD, PhD Thoracic Surgery University Hospitals Leuven Belgium Perspectives in Lung Cancer Brussels 6-7 march 2009 LEUVEN LUNG CANCER GROUP Department of Thoracic Surgery
More informationQuality of meta-analyses and why they sometimes lead to different conclusions
Quality of meta-analyses and why they sometimes lead to different conclusions Jean-Pierre Pignon, MD, PhD Service de Biostatistique et d Epidémiologie, Ligue Nationale Contre le Cancer metaanalysis platform,
More informationOutcome of nonsurgical treatment for locally advanced thymic tumors
Original Article Outcome of nonsurgical treatment for locally advanced thymic tumors Chang-Lu Wang 1, Lan-Ting Gao 1, Chang-Xing Lv 1, Lei Zhu 2, Wen-Tao Fang 3 1 Department of Radiation Oncology, 2 Department
More informationConcurrent and sequential chemoradiotherapy. P. Van Houtte Department of Radiation Oncology Institut Jules Bordet
Concurrent and sequential chemoradiotherapy and radiotherapy for NSCLC P. Van Houtte Department of Radiation Oncology Institut Jules Bordet RADIOTHERAPY & CHEMOTHERAPY A very old concept «Benzene could
More informationPROCARBAZINE, lomustine, and vincristine (PCV) is
RAPID PUBLICATION Procarbazine, Lomustine, and Vincristine () Chemotherapy for Anaplastic Astrocytoma: A Retrospective Review of Radiation Therapy Oncology Group Protocols Comparing Survival With Carmustine
More informationCetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice?
Cent. Eur. J. Med. 9(2) 2014 279-284 DOI: 10.2478/s11536-013-0154-9 Central European Journal of Medicine Cetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice? Jacopo Giuliani* 1, Marina
More informationCauses of Treatment Failure and Death in Carcinoma of the Lung
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 54 (1981), 201-207 Causes of Treatment Failure and Death in Carcinoma of the Lung JAMES D. COX, M.D.,a AND RAYMOND A. YESNER, M.D.b The Medical College of Wisconsin,
More informationUpdate on Small Cell Lung Cancer
Welcome to Master Class for Oncologists Session 4: 10:00 AM - 10:45 AM San Francisco, CA October 23, 2009 Speaker: Bruce E. Johnson, MD Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical
More informationRevisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis
Jpn J Clin Oncol 1997;27(5)305 309 Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis -, -, - - 1 Chest Department and 2 Section of Thoracic Surgery,
More informationEffect of radiotherapy on the treatment of patients with extensive stage small cell lung cancer
Effect of radiotherapy on the treatment of patients with extensive stage small cell lung cancer C. Wu, T. Wang, J. Wang, B. Qu, H. Wang and Y. Hu Department of Oncology, The General Hospital of the People
More informationPractice changing studies in lung cancer 2017
1 Practice changing studies in lung cancer 2017 Rolf Stahel University Hospital of Zürich Cape Town, February 16, 2018 DISCLOSURE OF INTEREST Consultant or Advisory Role in the last two years I have received
More informationIdentical chemotherapy schedules given on and off trial protocol in small cell lung cancer response and survival results
British Journal of Cancer (2002) 87, 562 566 All rights reserved 0007 0920/02 $25.00 www.bjcancer.com Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer response
More informationThe role of prophylactic brain irradiation in small cell lung cancer treatment
Monaldi Arch Chest Dis 2003; 59: 2, 128-133 REVIEW The role of prophylactic brain irradiation in small cell lung cancer treatment J.B. Sørensen ABSTRACT: The role of prophylactic brain irradiation in small
More informationRTOG Lung Cancer Committee 2012 Clinical Trial Update. Wally Curran RTOG Group Chairman
RTOG Lung Cancer Committee 2012 Clinical Trial Update Wally Curran RTOG Group Chairman 1 RTOG Lung Committee: Active Trials Small Cell Lung Cancer Limited Stage (Intergroup Trial) Extensive Stage (RTOG
More informationMultimodality treatment in limited small cell lung cancer (L-SCLC): different perspectives about the optimal approach
Perspective Multimodality treatment in limited small cell lung cancer (L-SCLC): different perspectives about the optimal approach Valentina Polo 1,2, Giulia Pasello 1 1 Medical Oncology 2, Venetian Oncology
More informationLung cancer is the leading cause of cancer-related death in
ORIGINAL ARTICLE Use of Adjuvant Chemotherapy in Non-small Cell Lung Cancer in Routine Practice Christophe Massard, MD,* Pierre Tran Ba Loc, MD, Vincent Haddad, MS, Jean-Pierre Pignon, MD, Philippe Girard,
More informationPatterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients
Original article Annals of Oncology 13: 748 754, 2002 DOI: 10.1093/annonc/mdf123 Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients
More informationCentral Nervous System Involvement and the Role of Prophylactic Cranial Irradiation in Small Cell Lung Cancer
Central Nervous System Involvement and the Role of Prophylactic Cranial Irradiation in Small Cell Lung Cancer C.G. ALEXOPOULOS, M. VASLAMATZIS, E. PATILA, L. TARANTO Department of Medical Oncology, Evangelismos
More informationAdjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas
Critical Reviews in Oncology/Hematology 56 (2005) 353 364 Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas Jacques Bernier a,, David G. Pfister b, Jay S. Cooper
More informationA PHASE II STUDY OF CISPLATIN AND 5-FLUOROURACIL COMBINATION CHEMOTHERAPY AND CONCURRENT THORACIC RADIATION IN SQUAMOUS CELL CARCINOMA OF LUNG
Original Article A PHASE II STUDY OF CISPLATIN AND 5-FLUOROURACIL COMBINATION CHEMOTHERAPY AND CONCURRENT THORACIC RADIATION IN SQUAMOUS CELL CARCINOMA OF LUNG Naeem Haider 1, Shaharyar 2, Shahid Rasul
More informationBasel Mnchen Paris London NewYork NewDelhi Bangkok Singapore Tokyo Sydney
19 Advances in Psychosomatic Medicine Editor: T.N. Wise Issues in Geriatric Psychiatry Editors : N. Billig, P.V. Rabins Issues in Geriatric Psychiatry Advances in Psychosomatic Medicine Vol. 19 Series
More informationDisclosure SBRT. SBRT for Spinal Metastases 5/2/2010. No conflicts of interest. Overview
Stereotactic Body Radiotherapy (SBRT) for Recurrent Spine Tumors Arjun Sahgal M.D., F.R.C.P.C. Assistant Professor Princess Margaret Hospital Sunnybrook Health Sciences Center University of Toronto Department
More informationLung Cancer Study Stage at diagnosis Days to first treatment First course of treatment Cancer Review Committee
Lung Cancer Study 2000-2011 Stage at diagnosis Days to first treatment First course of treatment Cancer Review Committee Stage of diagnosis of lung, bronchus non-small cell carcinoma cancer diagnosed in
More informationAccepted Manuscript. Risk stratification for distant recurrence of resected early stage NSCLC is under construction. Michael Lanuti, MD
Accepted Manuscript Risk stratification for distant recurrence of resected early stage NSCLC is under construction Michael Lanuti, MD PII: S0022-5223(17)32392-9 DOI: 10.1016/j.jtcvs.2017.10.063 Reference:
More informationDebate 1 Are treatments for small cell lung cancer getting better? No:
Debate 1 Are treatments for small cell lung cancer getting better? No: Taofeek Owonikoko, MD, PhD Associate Professor Department of Hematology & Medical Oncology Winship Cancer Institute of Emory University
More informationImpact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis
Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis D. De Ruysscher, B. Lueza, C. Le Péchoux, H. Johnson, M. O Brien,
More informationSan Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy
San Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy Kathleen C. Horst, M.D. Assistant Professor Department of Radiation Oncology Stanford University The Optimal SEquencing of Adjuvant Chemotherapy
More informationAccepted 28 April 2005 Published online 13 September 2005 in Wiley InterScience ( DOI: /hed.
DEFINING RISK LEVELS IN LOCALLY ADVANCED HEAD AND NECK CANCERS: A COMPARATIVE ANALYSIS OF CONCURRENT POSTOPERATIVE RADIATION PLUS CHEMOTHERAPY TRIALS OF THE EORTC (#22931) AND RTOG (#9501) Jacques Bernier,
More informationLUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS
LUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS William D. Travis, M.D. Attending Thoracic Pathologist Memorial Sloan Kettering Cancer Center New York, NY PULMONARY NE TUMORS CLASSIFICATION
More informationCombined drug and ionizing radiation: biological basis. Prof. Vincent GREGOIRE Université Catholique de Louvain, Cliniques Universitaires St-Luc
Combined drug and ionizing radiation: biological basis Prof. Vincent GREGOIRE Université Catholique de Louvain, Cliniques Universitaires St-Luc Pelvic radiation with concurrent chemotherapy compared with
More informationSecond Primary Cancers Related to Smoking and Treatment of Small-Cell Lung Cancer
- Second Primary Cancers Related to Smoking and Treatment of Small-Cell Lung Cancer Margaret A. Tucker, Nevin Murray, Edward G. Shaw, David S. Ettinger, Mack Mabry, Martin H. Huber, Ronald Feld, Frances
More information肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部
肺癌放射治療新進展 Recent Advance in Radiation Oncology in Lung Cancer 許峰銘成佳憲國立台灣大學醫學院附設醫院腫瘤醫學部 Outline Current status of radiation oncology in lung cancer Focused on stage III non-small cell lung cancer Radiation
More informationRadiotherapy for Locoregional Recurrent Non-Small Cell Lung Cancer
J Lung Cancer 2011;10(1):37-43 Radiotherapy for Locoregional Recurrent Non-Small Cell Lung Cancer Purpose: To retrospectively evaluate the outcomes and complications of curative radiotherapy for locoregionally
More informationBrain Metastases in Locally Advanced Nonsmall Cell Lung Carcinoma after Multimodality Treatment
605 Brain Metastases in Locally Advanced Nonsmall Cell Lung Carcinoma after Multimodality Treatment Risk Factors Analysis Giovanni Luca Ceresoli, M.D. 1 Michele Reni, M.D. 1 Giuseppe Chiesa, M.D. 2 Angelo
More informationLongcarcinoom: Literatuur en referenties
7.9.9. Longcarcinoom: Literatuur en referenties 1. Niet-invasieve stadiëring longcarcinoom - American Thoracic Society (ATS), European Respiratory Society (ERS). Pretreatment evaluation of non-small cell
More informationSchizophrenia: Positive and Negative Symptoms and Syndromes
Schizophrenia: Positive and Negative Symptoms and Syndromes Modern Problems of Pharmacopsychiatry Founded 1968 by F.A. Freyhant, N. Petrilowitscht, and P. Pichot Vol. 24 Series Editors T.A. Ban, Nashville,
More informationCâncer de Pulmão Não Pequenas Células
Câncer de Pulmão Não Pequenas Células Carboplatina + Paclitaxel Paclitaxel: 200mg/m 2 IV D1 Carboplatina: AUC 6 IV D1 a cada 21 dias X 4 ciclos Ref. (1) Vinorelbina + Cisplatina Vinorelbina: 25mg/m 2 IV
More informationCombined modality treatment for NSCLC with N2 disease
Combined modality treatment for NSCLC with N2 disease Gerry Hanna Senior Lecturer and Consultant in Clinical Oncology Centre for Cancer Research and Cell Biology @gerryhanna E: g.hanna@qub.ac.uk Talk Outline
More informationTHERAPY OF SMALL-CELL LUNG CANCER Peter Berzinec Specialised Hospital of St Zoerardus Zobor Teaching Base of the Slovak Medical University Nitra,
THERAPY OF SMALL-CELL LUNG CANCER Peter Berzinec Specialised Hospital of St Zoerardus Zobor Teaching Base of the Slovak Medical University Nitra, Slovakia Lancet. 1966;2(7471):979-86. First standard treatment:
More informationFinal Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer*
Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer* Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group William
More informationSMALL CELL LUNG CANCER Updated June 2018 by Dr. Kirstin Perdrizet (PGY-5 Medical Oncology Resident, University of Toronto)
SMALL CELL LUNG CANCER Updated June 2018 by Dr. Kirstin Perdrizet (PGY-5 Medical Oncology Resident, University of Toronto) Reviewed by Dr. Adrian Sacher (Staff Medical Oncologist, Princess Margaret Cancer
More informationTargeted Radiation +/- Biologics News Briefing
Targeted Radiation +/- Biologics News Briefing Wednesday, October 31, 2012 7:00 a.m. 7:45 a.m. Catherine Park, MD Vice-chairman of the ASTRO Education Committee Eric Chang, MD ASTRO Annual Meeting Scientific
More informationTristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease
Tristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease Jennifer E. Tseng, MD UFHealth Cancer Center-Orlando Health Sep 12, 2014 Background Approximately
More informationCombined Modality Therapy State of the Art. Everett E. Vokes The University of Chicago
Combined Modality Therapy State of the Art Everett E. Vokes The University of Chicago What we Know Some patients are cured (20%) Induction and concurrent chemoradiotherapy are each superior to radiotherapy
More informationACCELERATED BREAST IRRADIATION EVOLVING PARADIGM FOR TREATMENT OF EARLY STAGE BREAST CANCER
ACCELERATED BREAST IRRADIATION EVOLVING PARADIGM FOR TREATMENT OF EARLY STAGE BREAST CANCER KHANH NGUYEN, MD, MA DEPARTMENT OF RADIATION ONCOLOGY BAYHEALTH CANCER CENTER BREAST CANCER STATISTICS Most common
More information